Project

Moleculen

Algae Red

Our biotech innovation aims to reduce the high costs and inefficiencies in producing astaxanthin from Haematococcus pluvialis. The traditional process involves a lengthy cultivation phase and a costly, multi-step extraction method, making it difficult to scale and less affordable for industries like nutraceuticals and cosmetics.

We propose a two-part solution:

Optimizing cultivation with mixotrophy: By introducing sugar and CO₂ during the red phase, we reduce the time for astaxanthin accumulation, speeding up production and increasing output.

Microwave-Assisted Extraction (MAE) with Natural Deep Eutectic Solvents (NaDES): This simplifies extraction, reduces energy use, and enhances sustainability.

In the BB programme, we will optimize cultivation, test and scale MAE with NaDES, conduct pilot-scale experiments at AlgaePARC 2.0, and perform techno-economic and environmental assessments to ensure the process is cost-effective, scalable, and sustainable.

Project team

Judit Hunyadkurti

Project Number

BIOB24048

Year granted

2024

Applicant

Wageningen University & Research

Funding

€ 200.000

Sector/Industry

Food & Beverages

SDG's

Good health and well-being (SDG 3)
Climate action (SDG 13)
Life below water (SDG 14)

Thematic Cluster

TC2: Agriculture & Food
Molecuul

2024

Year granted

Wageningen University & Research

Applicant

€ 200.000

Project funded

Biotech Booster and CSL join forces to support biotech projects

Biotech Booster and CSL have taken a significant step towards accelerating biotech innovations. The organizations signed a collaboration agreement to

Biotech Booster and CSL join forces to support biotech projects

Three members from Biotech Booster projects receive personal grant by the Faculty of Impact

Congratulations to Fleur van Eeden, Dr. Brigit van Brenk, and Dr. Carina Nieuwenweg for receiving a personal grant by the

Three members from Biotech Booster projects receive personal grant by the Faculty of Impact
biotechnology netherlands

Meet EXIT071: advancing exosome isolation technology

Meet EXIT071, part of the first batch of Proof-of-Concept projects that joined the Biotech Booster program after the round of

Meet EXIT071: advancing exosome isolation technology

T-Guard receives approval to launch first-in-human trials

T-Guard is a Biotech Booster project addressing a significant unmet medical need in systemic sclerosis, a severe and debilitating autoimmune

T-Guard receives approval to launch first-in-human trials

Introducing Lieve van Veggel

In this series “Meet the people behind Biotech Booster” we introduce you to the passionate people who are involved in

Introducing Lieve van Veggel

Biotech Booster’s Annual Event 2025

On March 13th we had the privilege of hosting the second Annual Event of Biotech Booster at the AFAS Theater

Biotech Booster’s Annual Event 2025
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter